Andrew Tasseri
Analyst
Jefferies
Equibles does not estimate personal net worth.
About Andrew Tasseri
Andrew Tasseri is recorded as Analyst at Jefferies. Andrew Tasseri has spoken on 1 earnings call across 1 company, most recently for Vanda Pharmaceuticals Inc. on October 28, 2026. The companies whose calls Andrew Tasseri spoke on are classified in the Healthcare sector.
Andrew Tasseri on recent calls
“For MDD, if it succeeds in first half 2027, do you intend to file on a single Phase III, or do you plan to run another Phase III? And then secondly, on GPP, can you remind us the patient TAM and the pricing power you could have?”
Affiliation history
-
Jefferies
Analyst
Transcript header (unverified)
Current